Zevia raises $20M from GP Investments in strategic reset

What's the deal? Zevia, the NYSE-listed maker of zero-sugar, better-for-you beverages, has signed a definitive agreement to issue convertible preferred stock to a fund managed by GP Investments Ltd.Dealroom has a profile for this one. Try Dealroom → in exchange for $20 million of growth equity. The post-IPO convertible round, announced in October 2026, follows a 12-month review of strategic and financing options led by Piper SandlerDealroom has a profile for this one. Try Dealroom →.

Why now? Zevia and its board concluded the investment was "the best path forward to accelerate shareholder value creation" after weighing a broad range of alternatives. The deal strengthens the balance sheet and funds a strategic reset aimed at long-term growth.

Who's backing it? GP Investments, founded in the early 1990s by the entrepreneurs behind AB InBev and 3G, leads the round as a long-term strategic partner. Chief executive officer Alexandre Ruberti said the firm "brings a proven blueprint for building category-leading consumer businesses."

What's the endgame? The capital funds product innovation, a digital-first marketing push toward creators and micro-influencers, and a hybrid go-to-market strategy to drive household penetration. Zevia also plans to expand single-can availability and move into adjacent beverage categories.

GP Investments chief executive officer Rodrigo Boscolo said the team's "execution strengths and clear growth plan" position Zevia "to become a leading everyday alternative to traditional soda, as consumers increasingly seek healthier options without artificial sweeteners."

The signal: As demand grows for clean-label drinks without artificial sweeteners, Zevia is trading dilution for capital and operational expertise to defend and extend its shelf position. Backing from an investor with deep consumer-goods roots signals confidence that the category still has room to scale.

Read more: marketscreener.com

Image credit: Generated with Gemini